Arch Biopartners Eulerpool Nieuws

Arch Biopartners Eulerpool News

Arch Biopartners Aandeel Nieuws

Arch Biopartners wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Arch Biopartners nieuwsberichten verzamelen we hier.

• 16 oktober ·

  Yahoo
  Arch Biopartners Arranges Non-Brokered Private Placement
• 3 oktober ·

  Yahoo
  Closes Units for Debt Settlement
• 3 oktober ·

  Thefly.com
  Arch Biopartners closes units for debt settlement
• 26 september ·

  Yahoo
  Units for Debt Settlement
• 26 september ·

  Thefly.com
  Arch Biopartners announces units for debt settlement
• 11 september ·

  Yahoo
  Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
• 5 augustus ·

  Yahoo
  Arch Biopartners’ cilastatin enters Phase II trial for AKI prevention
• 2 augustus ·

  Yahoo
  Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 augustus ·

  GlobeNewswire
  Arch Biopartners? Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 augustus ·

  Thefly.com
  Arch Biopartners announces cilastatin to participate in PONTIAC Phase II trial